Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH and Early Ambulation for PE Prevention in Chinese Thoracic Surgery Patients
NCT03862755Phase 4Completed
- Start
- Aug 2017
- Primary completion
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of low molecular weight heparin calcium in pulmonary embolism (PE). Primary endpoint: Incidence of Postoperative Pulmonary Embolism at 8 weeks. Started Aug 2017; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT03862755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862755.